ABCG2 and hepatocellular carcinoma: Namisaki et al.105 recorded that ABCG2 expression, which is subject to modulation by the AKT signaling pathway, has a substantial role in mediating the efflux of chemotherapeutic agents like doxorubicin from HCC cells, thereby reducing their therapeutic effectiveness.